Maria S. Ponomareva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria S. Ponomareva has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Larisa A. Shchepankevitch
Novosibirsk State Medical University
13 shared publications - I. A. Gribacheva
Novosibirsk State Medical University
6 shared publications - Kseniya Viktorovna Rerikh
Novosibirsk State Medical University, Ministry of Health of Russia
6 shared publications - E. V. Petrova
Novosibirsk State Medical University, Ministry of Health of Russia
5 shared publications - Elena V. Taneeva
State Novosibirsk Regional Clinical Hospital
5 shared publications - T. F. Popova
Novosibirsk State Medical University
5 shared publications
Latest Publications
- 20 June 2026
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 18 (3)
Post-stroke cognitive impairment: risk factors and treatment approaches, use of memantine
Stroke remains the second leading cause of death worldwide, and post-stroke cognitive impairment (PSCI) is a common complication that ranges from mild impairments to dementia, negatively affecting memory, attention and learning, reducing quality of life and placing a greater burden on family carers. Factors associated with a poor prognosis include severe or recurrent stroke, advanced age, multifocal brain lesions and pre-existing cognitive impairment; pathologically, PSCI is associated with direct structural damage, disrupted neural connections and neurodegenerative changes (neuroinflammation, oxidative stress), making appropriate management of such patients particularly important. PSCI requires a comprehensive approach: secondary prevention, correction of vascular risk factors, and discontinuation of drugs with anticholinergic effects. There are no officially approved drugs for the treatment of PSCI: donepezil, which is effective in Alzheimer's disease, is of limited efficacy in PSCI and is associated with frequent adverse reactions, whereas memantine – a non-competitive NMDA receptor antagonist – reduces neuronal damage, improves cognitive function in ischaemia, slows functional decline and behavioural disturbances (agitation, aggression, irritability), enhances independence in daily living, and causes virtually no side effects. According to a network meta-analysis, memantine demonstrated the most significant effect on the Mini-Mental State Examination scale. The optimal time to start memantine therapy is 3–6 months after a stroke, and its domestic dispersible analogue (Memoritab®) is an effective and safe agent for managing cognitive function, particularly in patients with swallowing difficulties and low adherence to treatment. Memoritab, which is therapeutically equivalent to the original, improves patient adherence to treatment and facilitates their care thanks to its convenient formulation.
- 20 June 2026
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 18 (3)
Post-stroke cognitive impairment: risk factors and treatment approaches, use of memantine
Stroke remains the second leading cause of death worldwide, and post-stroke cognitive impairment (PSCI) is a common complication that ranges from mild impairments to dementia, negatively affecting memory, attention and learning, reducing quality of life and placing a greater burden on family carers. Factors associated with a poor prognosis include severe or recurrent stroke, advanced age, multifocal brain lesions and pre-existing cognitive impairment; pathologically, PSCI is associated with direct structural damage, disrupted neural connections and neurodegenerative changes (neuroinflammation, oxidative stress), making appropriate management of such patients particularly important. PSCI requires a comprehensive approach: secondary prevention, correction of vascular risk factors, and discontinuation of drugs with anticholinergic effects. There are no officially approved drugs for the treatment of PSCI: donepezil, which is effective in Alzheimer's disease, is of limited efficacy in PSCI and is associated with frequent adverse reactions, whereas memantine – a non-competitive NMDA receptor antagonist – reduces neuronal damage, improves cognitive function in ischaemia, slows functional decline and behavioural disturbances (agitation, aggression, irritability), enhances independence in daily living, and causes virtually no side effects. According to a network meta-analysis, memantine demonstrated the most significant effect on the Mini-Mental State Examination scale. The optimal time to start memantine therapy is 3–6 months after a stroke, and its domestic dispersible analogue (Memoritab®) is an effective and safe agent for managing cognitive function, particularly in patients with swallowing difficulties and low adherence to treatment. Memoritab, which is therapeutically equivalent to the original, improves patient adherence to treatment and facilitates their care thanks to its convenient formulation.
- 30 April 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 4,p. 551-560
Current approaches to the diagnosis and treatment of cere - bral venous thrombosis (based on the results of the work of Novosibirsk Regional Vascular Center No. 1)
In clinical practice, cerebral venous disorders are quite rare compared to disorders of arterial origin and account for only 0.5–2.5 %. Understanding the role of congenital and acquired thrombophilia is of particular relevance. With the discovery of new scientific data, it has become clear that many carriers of defective genes remain clinically healthy throughout life, although they are likely to develop this pathology under the influence of constant or temporary risk factors for thrombosis, such as surgery, trauma, estrogens, pregnancy, infections, physical and mental stress, diabetes mellitus, dyslipidemia, etc. Thus, thrombophilia should be discussed not only from a laboratory but also from a clinical perspective. The article analyzes cases of cerebral venous disorders based on data from Regional Vascular Center No. 1 of Novosibirsk.
- 30 April 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 4,p. 551-560
Current approaches to the diagnosis and treatment of cere - bral venous thrombosis (based on the results of the work of Novosibirsk Regional Vascular Center No. 1)
In clinical practice, cerebral venous disorders are quite rare compared to disorders of arterial origin and account for only 0.5–2.5 %. Understanding the role of congenital and acquired thrombophilia is of particular relevance. With the discovery of new scientific data, it has become clear that many carriers of defective genes remain clinically healthy throughout life, although they are likely to develop this pathology under the influence of constant or temporary risk factors for thrombosis, such as surgery, trauma, estrogens, pregnancy, infections, physical and mental stress, diabetes mellitus, dyslipidemia, etc. Thus, thrombophilia should be discussed not only from a laboratory but also from a clinical perspective. The article analyzes cases of cerebral venous disorders based on data from Regional Vascular Center No. 1 of Novosibirsk.
- Open Access
- 30 March 2026
- Published by ECO-Vector LLC (Publications) in Annals of Clinical and Experimental Neurology
- Vol. 20 (1) , 39-47
Ischemic stroke in young patients with obesity: the role of chronic non-specific inflammation
Introduction. Ischemic stroke (IS) in young adults remains an unresolved major medical, social, and demographic issue. In a quarter of cases of acute cerebrovascular events in young age their origin remains unknown (i.e., cryptogenic stroke). Obesity and its associated conditions are considered risk factors contributing to premature cerebro-metabolic disorders. Chronic non-specific inflammation (metabolic inflammation) is regarded as a potential key mechanism for vascular events in obesity, though its role in IS among obese individuals is not fully understood. Studying cytokine levels as primary markers of meta-inflammation will help assess its role in IS in young adults. The study aimed at evaluating the role of inflammatory mediators, biochemical and hemostatic statuses in young patients with IS of unknown etiology and obesity. Materials and methods. A prospective study included 66 patients aged 18–50 years with IS of unknown etiology, divided into two groups: subjects with obesity (body mass index (BMI) ≥30 kg/m2; n = 34) and subjects with normal BMI (18.5–24.9 kg/m2; n = 32). Anthropometric, blood chemistry (lipid profile — low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, glucose, C-reactive protein, uric acid, homocysteine), hemostatic (factors VIII, IX, von Willebrand factor (vWF), antithrombin III, protein C), and immune (tumor necrosis factor-α (TNF-α), interleukins-6, -8, -10) blood parameters were analyzed. Results. Significant differences were observed in key markers of chronic nonspecific inflammation among obese patients. Homocysteine levels (p = 0.0001), factors VIII (p = 0.024), IX (p = 0.003) and vWF (p 0.0001), antithrombin III (p = 0.0041), LDL cholesterol (p = 0.0382), HDL cholesterol (p = 0.0112), and uric acid (p = 0.0011) were significantly higher in obese patients. Sex stratification revealed that obesity significantly influenced triglyceride levels (p = 0.021 in men), LDL cholesterol (p = 0.0177 in men), HDL cholesterol (p = 0.0348 in men), uric acid (p = 0.0348 in men and p = 0.0229 in women), homocysteine (p = 0.0013 in women), vWF (p 0.0001 in both sexes), factor VIII (p = 0.0091 in men), factor IX (p = 0.0209 in women), and antithrombin III (p = 0.0048 in men). Similar changes were detected in inflammatory markers and proinflammatory cytokines (C-reactive protein, neutrophils, tumor necrosis factor-α, interleukin-8, -10) compared to patients with normal BMI. Conclusion. Adipose tissue-initiated chronic nonspecific inflammation plays a significant role in the IS of unknown etiology in young adults by initiating and exacerbating endothelial dysfunction, prothrombotic, and atherosclerotic changes.
- 30 March 2026
- Published by ECO-Vector LLC (Publications) in Annals of Clinical and Experimental Neurology
- Vol. 20 (1) , 39-47
Open AccessIschemic stroke in young patients with obesity: the role of chronic non-specific inflammation
Introduction. Ischemic stroke (IS) in young adults remains an unresolved major medical, social, and demographic issue. In a quarter of cases of acute cerebrovascular events in young age their origin remains unknown (i.e., cryptogenic stroke). Obesity and its associated conditions are considered risk factors contributing to premature cerebro-metabolic disorders. Chronic non-specific inflammation (metabolic inflammation) is regarded as a potential key mechanism for vascular events in obesity, though its role in IS among obese individuals is not fully understood. Studying cytokine levels as primary markers of meta-inflammation will help assess its role in IS in young adults. The study aimed at evaluating the role of inflammatory mediators, biochemical and hemostatic statuses in young patients with IS of unknown etiology and obesity. Materials and methods. A prospective study included 66 patients aged 18–50 years with IS of unknown etiology, divided into two groups: subjects with obesity (body mass index (BMI) ≥30 kg/m2; n = 34) and subjects with normal BMI (18.5–24.9 kg/m2; n = 32). Anthropometric, blood chemistry (lipid profile — low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, glucose, C-reactive protein, uric acid, homocysteine), hemostatic (factors VIII, IX, von Willebrand factor (vWF), antithrombin III, protein C), and immune (tumor necrosis factor-α (TNF-α), interleukins-6, -8, -10) blood parameters were analyzed. Results. Significant differences were observed in key markers of chronic nonspecific inflammation among obese patients. Homocysteine levels (p = 0.0001), factors VIII (p = 0.024), IX (p = 0.003) and vWF (p 0.0001), antithrombin III (p = 0.0041), LDL cholesterol (p = 0.0382), HDL cholesterol (p = 0.0112), and uric acid (p = 0.0011) were significantly higher in obese patients. Sex stratification revealed that obesity significantly influenced triglyceride levels (p = 0.021 in men), LDL cholesterol (p = 0.0177 in men), HDL cholesterol (p = 0.0348 in men), uric acid (p = 0.0348 in men and p = 0.0229 in women), homocysteine (p = 0.0013 in women), vWF (p 0.0001 in both sexes), factor VIII (p = 0.0091 in men), factor IX (p = 0.0209 in women), and antithrombin III (p = 0.0048 in men). Similar changes were detected in inflammatory markers and proinflammatory cytokines (C-reactive protein, neutrophils, tumor necrosis factor-α, interleukin-8, -10) compared to patients with normal BMI. Conclusion. Adipose tissue-initiated chronic nonspecific inflammation plays a significant role in the IS of unknown etiology in young adults by initiating and exacerbating endothelial dysfunction, prothrombotic, and atherosclerotic changes.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 10 (3)
CEREBRAL SMALL VESSEL DISEASE IN YOUNG PATIENTS WITH ISCHEMIC STROKE: PREVALENCE OF MARKERS AND IMPACT ON COGNITIVE OUTCOMES
Introduction. Cerebral small vessel disease (CSVD) is the leading cause of vascular cognitive impairment, accounting for 10–30% of all strokes. Despite the increasing incidence of ischemic stroke (IS) among young adults (under 50 years of age), the prevalence and pattern of CSVD MRI markers, as well as their role in the development of post-stroke cognitive impairment (PSCI) in this age group, remain poorly understood. Aim of the research. To assess the frequency and structure of CSVD markers using the CSVD total burden scale in young patients with ischemic stroke, and to analyze their correlation with cognitive outcomes in the acute and late recovery periods after ischemic stroke. Materials and methods. A prospective observational cohort study was performed, including 78 patients aged 18–50 years with first-time verified ischemic stroke (IS). MRI markers of CSVD (lacunae, white matter hyperintensities according to the Fazekas scale, cerebral microbleeds, dilated perivascular spaces) were assessed using the STRIVE2 criteria with calculation of the total CSVD score (0–4). Cognitive functions were assessed using the MoCA test in the acute period (T0, 3–7 days from IS onset), after 6 months (T6), and 12 months (T12). Patients were divided into two groups: SVD = 0 (n = 34) and SVD ≥ 1 (n = 44). Statistical analysis included two-way analysis of variance with repeated measures (mixed-effects model, REML), post-hoc analysis with correction for multiple comparisons, and correlation analysis. Results. SVD signs (SVD ≥ 1) were detected in 56.41% of patients. The most common marker was dilated perivascular spaces (39.56%), the least common was cerebral microbleeds (12.09%). The most common paired combination was lacunae and perivascular spaces (12.82%). A moderate negative correlation was found between the total SVD score and MoCA scores at all time points (r from -0.44 to -0.57), most pronounced at 12 months (r = -0.57). In the acute period, no significant intergroup differences in MoCA were found (p = 0.1518), however, after 6 months (mean difference -3.868; p = 0.0285) and 12 months (mean difference -4.387; p = 0.0105), patients with SVD ≥ 1 demonstrated significantly lower cognitive scores. The dynamics of cognitive functions was characterized by improvement in both groups over the course of a year (p = 0.0242). Conclusion. More than half of young patients with ischemic stroke have signs of small vessel disease. Dilated perivascular spaces are the most common and potentially early marker of CSVD in this patient population. The presence of CSVD (SVD ≥ 1) is associated with persistent cognitive deficits late after stroke, justifying the need for routine MRI assessment of perivascular dystonia markers to stratify the risk of cognitive impairment and individualize neurorehabilitation programs in young patients.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 10 (3)
CEREBRAL SMALL VESSEL DISEASE IN YOUNG PATIENTS WITH ISCHEMIC STROKE: PREVALENCE OF MARKERS AND IMPACT ON COGNITIVE OUTCOMES
Introduction. Cerebral small vessel disease (CSVD) is the leading cause of vascular cognitive impairment, accounting for 10–30% of all strokes. Despite the increasing incidence of ischemic stroke (IS) among young adults (under 50 years of age), the prevalence and pattern of CSVD MRI markers, as well as their role in the development of post-stroke cognitive impairment (PSCI) in this age group, remain poorly understood. Aim of the research. To assess the frequency and structure of CSVD markers using the CSVD total burden scale in young patients with ischemic stroke, and to analyze their correlation with cognitive outcomes in the acute and late recovery periods after ischemic stroke. Materials and methods. A prospective observational cohort study was performed, including 78 patients aged 18–50 years with first-time verified ischemic stroke (IS). MRI markers of CSVD (lacunae, white matter hyperintensities according to the Fazekas scale, cerebral microbleeds, dilated perivascular spaces) were assessed using the STRIVE2 criteria with calculation of the total CSVD score (0–4). Cognitive functions were assessed using the MoCA test in the acute period (T0, 3–7 days from IS onset), after 6 months (T6), and 12 months (T12). Patients were divided into two groups: SVD = 0 (n = 34) and SVD ≥ 1 (n = 44). Statistical analysis included two-way analysis of variance with repeated measures (mixed-effects model, REML), post-hoc analysis with correction for multiple comparisons, and correlation analysis. Results. SVD signs (SVD ≥ 1) were detected in 56.41% of patients. The most common marker was dilated perivascular spaces (39.56%), the least common was cerebral microbleeds (12.09%). The most common paired combination was lacunae and perivascular spaces (12.82%). A moderate negative correlation was found between the total SVD score and MoCA scores at all time points (r from -0.44 to -0.57), most pronounced at 12 months (r = -0.57). In the acute period, no significant intergroup differences in MoCA were found (p = 0.1518), however, after 6 months (mean difference -3.868; p = 0.0285) and 12 months (mean difference -4.387; p = 0.0105), patients with SVD ≥ 1 demonstrated significantly lower cognitive scores. The dynamics of cognitive functions was characterized by improvement in both groups over the course of a year (p = 0.0242). Conclusion. More than half of young patients with ischemic stroke have signs of small vessel disease. Dilated perivascular spaces are the most common and potentially early marker of CSVD in this patient population. The presence of CSVD (SVD ≥ 1) is associated with persistent cognitive deficits late after stroke, justifying the need for routine MRI assessment of perivascular dystonia markers to stratify the risk of cognitive impairment and individualize neurorehabilitation programs in young patients.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 10 (2)
The course of cryptogenic ischemic stroke in young adults with obesity
Introduction. Ischemic stroke (IS) in young adults, or premature stroke, is becoming increasingly significant due to its rising incidence and the high proportion of patients with unspecified etiology (UE). Obesity, a currently widespread pathology and a key risk factor for cardiovascular diseases, may exacerbate the course of IS. Aim. The assessment of neurological deficit, severity, and the degree of disability in the hyperacute and acute phases of IS of UE, i.e. cryptogenic stroke, in young patients based on the presence or absence of obesity. Materials and methods. The prospective study included two groups of patients with cryptogenic IS, aged 18–50 years: the main group of 34 patients with obesity (body mass index (BMI) >30,0 kg/m2) and the comparison group of 32 patients without obesity (BMI 18,5–24,9 kg/m2). Clinical, anthropometric, and demographic parameters were assessed. Functional status was evaluated using the modified Rankin Scale (mRS), and neurological deficit – using the National Institutes of Health Stroke Scale (NIHSS). Results. The analysis of neurological symptoms in the hyperacute phase of stroke revealed no statistically significant differences between the groups, except for seizure syndrome at the onset, which was observed only in obese patients (11,76%, p = 0,045). The severity of the disease (assessed by the NIHSS) was significantly higher in the obesity group both at admission (7,26 ± 1,62 vs. 5,68 ± 3,89; p = 0,04) and on day 21 ± 5 (2,71 ± 2,1 vs. 1,81 ± 1,35; p = 0,043). However, the early functional outcomes (assessed by the mRS) by day 21 ± 5 showed no significant differences between the groups (1,91 ± 1,4 vs. 1,47 ± 1,2; p = 0,2). Conclusion. Stroke in young obese patients is characterized by a more severe course, likely due to the influence of dysfunctional adipose tissue, which contributes to development of systemic inflammation and metabolic disorders.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 10 (2)
The course of cryptogenic ischemic stroke in young adults with obesity
Introduction. Ischemic stroke (IS) in young adults, or premature stroke, is becoming increasingly significant due to its rising incidence and the high proportion of patients with unspecified etiology (UE). Obesity, a currently widespread pathology and a key risk factor for cardiovascular diseases, may exacerbate the course of IS. Aim. The assessment of neurological deficit, severity, and the degree of disability in the hyperacute and acute phases of IS of UE, i.e. cryptogenic stroke, in young patients based on the presence or absence of obesity. Materials and methods. The prospective study included two groups of patients with cryptogenic IS, aged 18–50 years: the main group of 34 patients with obesity (body mass index (BMI) >30,0 kg/m2) and the comparison group of 32 patients without obesity (BMI 18,5–24,9 kg/m2). Clinical, anthropometric, and demographic parameters were assessed. Functional status was evaluated using the modified Rankin Scale (mRS), and neurological deficit – using the National Institutes of Health Stroke Scale (NIHSS). Results. The analysis of neurological symptoms in the hyperacute phase of stroke revealed no statistically significant differences between the groups, except for seizure syndrome at the onset, which was observed only in obese patients (11,76%, p = 0,045). The severity of the disease (assessed by the NIHSS) was significantly higher in the obesity group both at admission (7,26 ± 1,62 vs. 5,68 ± 3,89; p = 0,04) and on day 21 ± 5 (2,71 ± 2,1 vs. 1,81 ± 1,35; p = 0,043). However, the early functional outcomes (assessed by the mRS) by day 21 ± 5 showed no significant differences between the groups (1,91 ± 1,4 vs. 1,47 ± 1,2; p = 0,2). Conclusion. Stroke in young obese patients is characterized by a more severe course, likely due to the influence of dysfunctional adipose tissue, which contributes to development of systemic inflammation and metabolic disorders.
- Open Access
- 15 March 2025
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 19 (1) , 21-29
Metabolic predictors of ischemic stroke in young adults
Introduction. Ischemic stroke (IS) has a tendency towards younger age of onset among working-age adults, with an increasing role of obesity in IS development. New prognostic markers affecting stroke severity and early outcomes are being sought. Aim: to investigate etiology and risk factors of cryptogenic IS in working-age patients (18–50 years) and evaluate the significance of metabolic markers of obesity and hemostasis in predicting immediate disease outcomes. Materials and methods. We retrospectively analyzed 343 medical records of acute stroke patients aged 18–50 years using clinical, laboratory, and imaging findings and calculated risk levels. Results. Obesity was observed in more than half (51.3%) of the patients. Early atherosclerotic changes in the vessel wall were detected in 62.26% of the cases. Worse immediate stroke outcomes were associated with all obesity parameters: body mass index (r = 0.48), waist circumference (WC) (r = 0.43), waist-to-hip ratio (WHR) (r = 0.52), levels of glucose (r = 0.47), C-reactive protein (r = 0.34), hematocrit (r = 0.41), high-density lipoproteins (r = –0.32), von Willebrand factor (r = 0.58), fibrinogen (r = 0.66), FVIII (r = 0.50), D-dimer (r = 0.50), and ADP-induced platelet aggregation (r = 0.41). Stroke severity was found to correlate with levels of triglycerides (r = 0.57), low-density lipoproteins (r = 0.35), von Willebrand factor (r = 0.55), fibrinogen (r = 0.46), coagulation factor VIII (r = 0.63), D-dimer (r = 0.39), antithrombin III (r = 0.39), and WHR (r = 0.53). Receiver operating characteristic curves revealed triglyceride-glucose index to be a predictor of worse early outcome (area under the curve, 0.66; threshold, 4.7), including in terms of WC (0.68 and 497.6, respectively) or stroke severity (0.63 and 4.7, respectively). Conclusion. IS in young adults is accompanied by impaired metabolism, affecting the disease outcome. Indices including glucose, triglycerides, and the obesity status can play a role in predicting the stroke severity in young adults, among others.
- 15 March 2025
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 19 (1) , 21-29
Open AccessMetabolic predictors of ischemic stroke in young adults
Introduction. Ischemic stroke (IS) has a tendency towards younger age of onset among working-age adults, with an increasing role of obesity in IS development. New prognostic markers affecting stroke severity and early outcomes are being sought. Aim: to investigate etiology and risk factors of cryptogenic IS in working-age patients (18–50 years) and evaluate the significance of metabolic markers of obesity and hemostasis in predicting immediate disease outcomes. Materials and methods. We retrospectively analyzed 343 medical records of acute stroke patients aged 18–50 years using clinical, laboratory, and imaging findings and calculated risk levels. Results. Obesity was observed in more than half (51.3%) of the patients. Early atherosclerotic changes in the vessel wall were detected in 62.26% of the cases. Worse immediate stroke outcomes were associated with all obesity parameters: body mass index (r = 0.48), waist circumference (WC) (r = 0.43), waist-to-hip ratio (WHR) (r = 0.52), levels of glucose (r = 0.47), C-reactive protein (r = 0.34), hematocrit (r = 0.41), high-density lipoproteins (r = –0.32), von Willebrand factor (r = 0.58), fibrinogen (r = 0.66), FVIII (r = 0.50), D-dimer (r = 0.50), and ADP-induced platelet aggregation (r = 0.41). Stroke severity was found to correlate with levels of triglycerides (r = 0.57), low-density lipoproteins (r = 0.35), von Willebrand factor (r = 0.55), fibrinogen (r = 0.46), coagulation factor VIII (r = 0.63), D-dimer (r = 0.39), antithrombin III (r = 0.39), and WHR (r = 0.53). Receiver operating characteristic curves revealed triglyceride-glucose index to be a predictor of worse early outcome (area under the curve, 0.66; threshold, 4.7), including in terms of WC (0.68 and 497.6, respectively) or stroke severity (0.63 and 4.7, respectively). Conclusion. IS in young adults is accompanied by impaired metabolism, affecting the disease outcome. Indices including glucose, triglycerides, and the obesity status can play a role in predicting the stroke severity in young adults, among others.
- 1 March 2025
- Published by MEDIKON LLC in Comorbidity neurology
- Vol. 2 (1)
Features of Treatment of Vascular Cognitive Disorders in Patients with Dysphalgia: a Review
INTRODUCTION. The risk of developing dementia increases with each decade of life, with vascular etiology accounting for 20%. An aggravating factor is dysphagia, which increases the risk of complications and limits correct therapy. AIM. To summarize current concepts of treating patients with vascular dementia and dysphagia. MATERIALS AND METHODS. In total, more than 100 publications were identified in the PubMed database using the keywords “dysphagia”, “dementia”, “treating” and in the scientific library Elibrary using the keywords “vascular cognitive disorders, dysphagia, treatment”. RESULTS AND DISCUSSION. Swallowing disorders are highly prevalent in older adults with dementia. Dysphagia management includes bolus modification, use of special postures, and rehabilitation interventions. Tableted medications are a major problem, and alternative formulations such as memantine dispersible tablets (Memoritab) are helpful. The ease of administration of this formulation increases patient compliance and provides relief for caregivers. CONCLUSION. The dispersible form of memantine (Memoritab) is an effective and safe alternative to tablet forms of the drug in the treatment of vascular cognitive impairment in patients with dysphagia.
- 1 March 2025
- Published by MEDIKON LLC in Comorbidity neurology
- Vol. 2 (1)
Features of Treatment of Vascular Cognitive Disorders in Patients with Dysphalgia: a Review
INTRODUCTION. The risk of developing dementia increases with each decade of life, with vascular etiology accounting for 20%. An aggravating factor is dysphagia, which increases the risk of complications and limits correct therapy. AIM. To summarize current concepts of treating patients with vascular dementia and dysphagia. MATERIALS AND METHODS. In total, more than 100 publications were identified in the PubMed database using the keywords “dysphagia”, “dementia”, “treating” and in the scientific library Elibrary using the keywords “vascular cognitive disorders, dysphagia, treatment”. RESULTS AND DISCUSSION. Swallowing disorders are highly prevalent in older adults with dementia. Dysphagia management includes bolus modification, use of special postures, and rehabilitation interventions. Tableted medications are a major problem, and alternative formulations such as memantine dispersible tablets (Memoritab) are helpful. The ease of administration of this formulation increases patient compliance and provides relief for caregivers. CONCLUSION. The dispersible form of memantine (Memoritab) is an effective and safe alternative to tablet forms of the drug in the treatment of vascular cognitive impairment in patients with dysphagia.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 9 (3)
COGNITIVE FUNCTIONS AND LEVELS OF REGULATORY NEUROTRANSMITTERS UNDER COMBINED INFLUENCE OF AUDIOVISUAL AND MAGNETIC STIMULATION OF BRAIN STRUCTURES
Introduction. Identifying potential factors that can improve cognitive abilities is of great interest, but the role of non-drug alternative approaches is underestimated. Recent studies have proven the role of mediator effects in the state and functioning of human higher nervous activity; studies of the effects of non-invasive brain stimulation, along with the use of cognitive tests, increase the objectivity of the effect being studied, and allow us to make an assumption about the possible mechanisms of this phenomenon. Aim of the research. To identify the effect of audiovisual and magnetic stimulation of brain structures from the device according to specification 32.50.21.112-018-39136787-2023 on the parameters of cognitive functions (CF) and the levels of regulatory neurotransmitters in healthy volunteers. Materials and methods. A total of 40 healthy volunteers (men and women) with an average age of 42.4 ± 4.5 years were examined during three visits with an interval of 2-4 weeks. The volunteers were randomly divided into two groups: Group 1 — experimental (30 people), received a course of audiovisual and magnetic stimulation of brain structures from the device according to specification 32.50.21.112-018-39136787-2023 for 10 days. Group 2 — comparison (10 people), underwent only a dynamic examination. In both groups, a standard electroencephalographic (EEG) examination was performed at baseline and after 2 weeks with the implementation of generally accepted functional tests. Cognitive functions of the central nervous system were determined using Gorbov's Red-Black Table and the Remember and Place Dots test. The degree of intensity of metabolic and compensatory-adaptive reactions was assessed by radioimmune analysis of blood plasma for levels of cortisol, IRI, adrenaline, noradrenaline, dopamine, serotonin using the RIG-12 Progress-RIA device. Results. Upon completion of the course of audio-visual and magnetic stimulation of the brain structures in those examined in Group 1, according to the Red-Black Tables test, by the second visit there was a decrease in the Attention Switching Time indicator by 1.15 times (p > 0.05); according to the Remember and Place Dots test, there was an increase in the Perception Accuracy indicator by 1.4 times (p = 0.032), which went up by the third visit to 1.75 times from the initial values (p = 0.01). In the comparison group, the studied parameter remained stable throughout the observation period, which resulted in reliable differences between the Perception Accuracy indicators between the groups at the second visit – by 1.5 times (p = 0.018), ran up to 2 times – by the third visit (p = 0.01). The change in the level of neurotransmitters was realized in the increase in the levels of serotonin in the blood plasma of the examined group 1 by 1.3 times (p = 0.037) and dopamine by 1.27 times (p = 0.045), norepinephrine by 1.25 times (p = 0.043), from the initial values. At the same time, the changes in the levels of the studied indicators in group 2 were not significant. Conclusion. Audiovisual and magnetic stimulation of the central nervous system from the device according to specification 32.50.21.112-018-39136787-2023 in healthy volunteers with an average age of 42.4 ± 4.5 years improves neurodynamic cognitive functions, including the time of switching attention and the accuracy of perception, and promotes shifts in the blood plasma levels of neurotransmitters involved in the regulation of compensatory-adaptive reactions.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 9 (3)
COGNITIVE FUNCTIONS AND LEVELS OF REGULATORY NEUROTRANSMITTERS UNDER COMBINED INFLUENCE OF AUDIOVISUAL AND MAGNETIC STIMULATION OF BRAIN STRUCTURES
Introduction. Identifying potential factors that can improve cognitive abilities is of great interest, but the role of non-drug alternative approaches is underestimated. Recent studies have proven the role of mediator effects in the state and functioning of human higher nervous activity; studies of the effects of non-invasive brain stimulation, along with the use of cognitive tests, increase the objectivity of the effect being studied, and allow us to make an assumption about the possible mechanisms of this phenomenon. Aim of the research. To identify the effect of audiovisual and magnetic stimulation of brain structures from the device according to specification 32.50.21.112-018-39136787-2023 on the parameters of cognitive functions (CF) and the levels of regulatory neurotransmitters in healthy volunteers. Materials and methods. A total of 40 healthy volunteers (men and women) with an average age of 42.4 ± 4.5 years were examined during three visits with an interval of 2-4 weeks. The volunteers were randomly divided into two groups: Group 1 — experimental (30 people), received a course of audiovisual and magnetic stimulation of brain structures from the device according to specification 32.50.21.112-018-39136787-2023 for 10 days. Group 2 — comparison (10 people), underwent only a dynamic examination. In both groups, a standard electroencephalographic (EEG) examination was performed at baseline and after 2 weeks with the implementation of generally accepted functional tests. Cognitive functions of the central nervous system were determined using Gorbov's Red-Black Table and the Remember and Place Dots test. The degree of intensity of metabolic and compensatory-adaptive reactions was assessed by radioimmune analysis of blood plasma for levels of cortisol, IRI, adrenaline, noradrenaline, dopamine, serotonin using the RIG-12 Progress-RIA device. Results. Upon completion of the course of audio-visual and magnetic stimulation of the brain structures in those examined in Group 1, according to the Red-Black Tables test, by the second visit there was a decrease in the Attention Switching Time indicator by 1.15 times (p > 0.05); according to the Remember and Place Dots test, there was an increase in the Perception Accuracy indicator by 1.4 times (p = 0.032), which went up by the third visit to 1.75 times from the initial values (p = 0.01). In the comparison group, the studied parameter remained stable throughout the observation period, which resulted in reliable differences between the Perception Accuracy indicators between the groups at the second visit – by 1.5 times (p = 0.018), ran up to 2 times – by the third visit (p = 0.01). The change in the level of neurotransmitters was realized in the increase in the levels of serotonin in the blood plasma of the examined group 1 by 1.3 times (p = 0.037) and dopamine by 1.27 times (p = 0.045), norepinephrine by 1.25 times (p = 0.043), from the initial values. At the same time, the changes in the levels of the studied indicators in group 2 were not significant. Conclusion. Audiovisual and magnetic stimulation of the central nervous system from the device according to specification 32.50.21.112-018-39136787-2023 in healthy volunteers with an average age of 42.4 ± 4.5 years improves neurodynamic cognitive functions, including the time of switching attention and the accuracy of perception, and promotes shifts in the blood plasma levels of neurotransmitters involved in the regulation of compensatory-adaptive reactions.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (3)
Audiovisual and magnetic brain stimulation in rehabilitation of post-stroke cognitive impairment (literature review)
Stroke is a pressing medical problem that causes significant socio-economic losses. Post-stroke cognitive impairment negatively affects rehabilitation outcomes, increases the likelihood of recurrent stroke and premature death. In the management of post-stroke cognitive impairment, significant attention is paid to the use of non-invasive physical brain stimulation – audiovisual stimulation, transcranial magnetic stimulation (TMS) and transcranial direct or alternating current electrical stimulation. The mechanism of audiovisual impact on the state of the brain is due to the formation of a dominant rhythm of electrocortical activity, the biological effects of weak magnetic fields are determined by chemical processes responsible for enzymatic DNA synthesis, which can stimulate processes of neuroplasticity in stroke patients and affect the cognitive functions. The most promising in the treatment of post-stroke cognitive impairment are considered to be modern directions of TMS: high-frequency or low-frequency repetitive TMS (rTMS), intermittent theta pulse stimulation, which have demonstrated safety and effectiveness. In recent years, in the set of rehabilitation programs for the recovery of post-stroke cognitive deficit multimodal interventions have been widely used, including physical exercises, walking, cognitive and aerobic training. The data presented in the review indicate that the inclusion of transcranial low- and high-intensity pulsed magnetic field therapy, audiovisual stimulation of brain structures into rehabilitation programs for post-ischemic stroke patients contributes to the improvement of attention, speech, gnosis, delayed memory and orientation, and increases the functional level of the central nervous system.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (3)
Audiovisual and magnetic brain stimulation in rehabilitation of post-stroke cognitive impairment (literature review)
Stroke is a pressing medical problem that causes significant socio-economic losses. Post-stroke cognitive impairment negatively affects rehabilitation outcomes, increases the likelihood of recurrent stroke and premature death. In the management of post-stroke cognitive impairment, significant attention is paid to the use of non-invasive physical brain stimulation – audiovisual stimulation, transcranial magnetic stimulation (TMS) and transcranial direct or alternating current electrical stimulation. The mechanism of audiovisual impact on the state of the brain is due to the formation of a dominant rhythm of electrocortical activity, the biological effects of weak magnetic fields are determined by chemical processes responsible for enzymatic DNA synthesis, which can stimulate processes of neuroplasticity in stroke patients and affect the cognitive functions. The most promising in the treatment of post-stroke cognitive impairment are considered to be modern directions of TMS: high-frequency or low-frequency repetitive TMS (rTMS), intermittent theta pulse stimulation, which have demonstrated safety and effectiveness. In recent years, in the set of rehabilitation programs for the recovery of post-stroke cognitive deficit multimodal interventions have been widely used, including physical exercises, walking, cognitive and aerobic training. The data presented in the review indicate that the inclusion of transcranial low- and high-intensity pulsed magnetic field therapy, audiovisual stimulation of brain structures into rehabilitation programs for post-ischemic stroke patients contributes to the improvement of attention, speech, gnosis, delayed memory and orientation, and increases the functional level of the central nervous system.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 9 (2)
INFLUENCE OF AUDIOVISUAL AND MAGNETIC STIMULATION OF BRAIN STRUCTURES ON ELECTROENCEPHALOGRAM PARAMETERS AND COGNITIVE FUNCTIONS
Introduction. External physical stimuli of certain characteristics can affect the parameters of the rhythms of the cerebral cortex (CC), influencing the cognitive abilities of an individual, which will serve as a basis for the inclusion of audiovisual and magnetic stimulation of the structures of the central nervous system (CNS) in a neurological clinic. Aim of the research. To identify the effect of audiovisual and magnetic stimulation of the brain structures from the device according to TU 32.50.21.112-018-39136787-2023 on the parameters of the electroencephalogram and cognitive functions (CF) of healthy volunteers. Materials and methods. A total of 40 healthy volunteers (men and women) with a mean age of 42.4 ± 4.5 years were examined during three visits with an interval of 2-4 weeks. The volunteers were randomly divided into two groups: Group 1 – experimental (30 people), received a course of audiovisual and magnetic stimulation of the cerebral structures from the device according to TU 32.50.21.112-018-39136787-2023 for 10 days. Group 2 – comparison one (10 people), underwent only a dynamic examination. In both groups, a standard electroencephalographic (EEG) examination was performed at baseline and after 2 weeks with the implementation of generally accepted functional tests. Cognitive functions of the central nervous system were determined using Schulte tables. Results. Upon completion of the course of audiovisual and magnetic stimulation of the brain structures, those examined during the EEG functional tests showed a greater depression of the alpha rhythm than those in the comparison group. Desynchronization in the low-frequency subranges of the alpha rhythm (6-10 Hz) was ob-served when performing tests that required involvement and attention. In patients from group 1, when per-forming functional tests, a more significant increase in the amplitude of the theta rhythm in the EEG was noted than in group 2. By the second visit, those examined in group 1 showed, according to Schulte tables, a reliable correction of the “Mental stability” indicator (p = 0.021), which remained at the same level by the third visit. The Degree of workability indicator significantly improved by the third visit from the initial values – by 1.19 times (p = 0.043). In group 2, the studied indicators remained stable throughout the observation period. Conclusion. Audiovisual and magnetic stimulation of the central nervous system from the device according to TU 32.50.21.112-018-39136787-2023 in healthy volunteers with a mean age of 42.4 ± 4.5 years contributes to shifts in the EEG state, causing a tendency to a greater depression of the alpha rhythm than in the comparison group, with a simultaneous increase in the amplitude of the theta rhythm on the EEG, improves neurodynamic cognitive functions, including increased work efficiency, the degree of working in and mental stability.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 9 (2)
INFLUENCE OF AUDIOVISUAL AND MAGNETIC STIMULATION OF BRAIN STRUCTURES ON ELECTROENCEPHALOGRAM PARAMETERS AND COGNITIVE FUNCTIONS
Introduction. External physical stimuli of certain characteristics can affect the parameters of the rhythms of the cerebral cortex (CC), influencing the cognitive abilities of an individual, which will serve as a basis for the inclusion of audiovisual and magnetic stimulation of the structures of the central nervous system (CNS) in a neurological clinic. Aim of the research. To identify the effect of audiovisual and magnetic stimulation of the brain structures from the device according to TU 32.50.21.112-018-39136787-2023 on the parameters of the electroencephalogram and cognitive functions (CF) of healthy volunteers. Materials and methods. A total of 40 healthy volunteers (men and women) with a mean age of 42.4 ± 4.5 years were examined during three visits with an interval of 2-4 weeks. The volunteers were randomly divided into two groups: Group 1 – experimental (30 people), received a course of audiovisual and magnetic stimulation of the cerebral structures from the device according to TU 32.50.21.112-018-39136787-2023 for 10 days. Group 2 – comparison one (10 people), underwent only a dynamic examination. In both groups, a standard electroencephalographic (EEG) examination was performed at baseline and after 2 weeks with the implementation of generally accepted functional tests. Cognitive functions of the central nervous system were determined using Schulte tables. Results. Upon completion of the course of audiovisual and magnetic stimulation of the brain structures, those examined during the EEG functional tests showed a greater depression of the alpha rhythm than those in the comparison group. Desynchronization in the low-frequency subranges of the alpha rhythm (6-10 Hz) was ob-served when performing tests that required involvement and attention. In patients from group 1, when per-forming functional tests, a more significant increase in the amplitude of the theta rhythm in the EEG was noted than in group 2. By the second visit, those examined in group 1 showed, according to Schulte tables, a reliable correction of the “Mental stability” indicator (p = 0.021), which remained at the same level by the third visit. The Degree of workability indicator significantly improved by the third visit from the initial values – by 1.19 times (p = 0.043). In group 2, the studied indicators remained stable throughout the observation period. Conclusion. Audiovisual and magnetic stimulation of the central nervous system from the device according to TU 32.50.21.112-018-39136787-2023 in healthy volunteers with a mean age of 42.4 ± 4.5 years contributes to shifts in the EEG state, causing a tendency to a greater depression of the alpha rhythm than in the comparison group, with a simultaneous increase in the amplitude of the theta rhythm on the EEG, improves neurodynamic cognitive functions, including increased work efficiency, the degree of working in and mental stability.